Utilization of sentinel lymph node biopsy in patients with ductal carcinoma in situ undergoing mastectomy.

ABSTRACT:

Background

Current guidelines suggest consideration of sentinel lymph node biopsy (SLNB) for patients with ductal carcinoma in situ (DCIS) undergoing mastectomy. Our objective was to identify factors influencing the utilization of SLNB in this population.

Methods

We used the Surveillance Epidemiology and End Results database to identify all women with breast DCIS treated with mastectomy from 2000 to 2008. We excluded patients without histologic confirmation, those diagnosed at autopsy, those who had axillary lymph node dissections performed without a preceding SLNB, and those for whom the status of SLNB was unknown. We used multivariate logistic regression reporting odds ratios (OR) and 95% confidence intervals (CI) to evaluate the relationship of patient- and tumor-related

SUBMITTER: Shah DR 

PROVIDER: S-EPMC4601634 | biostudies-literature | 2013 Jan

REPOSITORIES: biostudies-literature